Nexium (Esomeprazole Magnesium Trihydrate)

Nexium, a proton pump inhibitor, acts on the gastric acid secretion pathway to treat several acid‑related disorders.

• Gastro‑oesophageal reflux disease (GERD): alleviates heartburn and regurgitation by maintaining higher gastric pH.
• Erosive esophagitis: promotes healing of inflamed esophageal lining and prevents further erosion.
• Peptic ulcer disease: supports ulcer resolution by suppressing acid that impedes mucosal repair.
• Helicobacter pylori eradication (combined therapy): enhances the effectiveness of antibiotic regimens by creating a less acidic gastric environment.

• Esomeprazole magnesium trihydrate is the S‑enantiomer of omeprazole that selectively and irreversibly binds to the cysteine residues of the H⁺/K⁺‑ATPase enzyme (gastric proton pump) located on the secretory surface of parietal cells. By inhibiting this final step of acid secretion, it markedly reduces basal and stimulated gastric acid output, leading to increased gastric pH. The effect persists for up to 72 hours, allowing once‑daily dosing in most patients.

Esomeprazole may be associated with a range of adverse reactions, which are generally classified by frequency and severity.

Common Side Effects

• Headache: mild to moderate pain often transient.
• Diarrhea: loose stools that may resolve with continued therapy.
• Nausea: feeling of stomach upset, usually mild.
• Abdominal pain: discomfort or cramping in the stomach area.

Serious or Rare Side Effects

• Severe allergic reaction (anaphylaxis): rash, swelling, difficulty breathing requiring immediate medical attention.
• Clostridioides difficile infection: persistent watery diarrhea and abdominal pain indicating possible colitis.
• Low serum magnesium (hypomagnesemia): muscle weakness, tremors, or cardiac arrhythmias, especially with prolonged use.
• Bone fracture risk: decreased calcium absorption leading to osteoporosis with long‑term use.

When prescribing esomeprazole, clinicians should consider several precautionary measures to ensure safe use.

• Assess renal function: dose adjustment may be needed in severe impairment.
• Evaluate for CYP2C19 polymorphism: reduced metabolism can increase drug exposure.
• Monitor magnesium levels: prolonged therapy can lead to hypomagnesemia.
• Use lowest effective dose: limit duration to the shortest period required for healing.
• Avoid concomitant use with known major interacting drugs unless benefits outweigh risks.
• Store at ambient temperature: keep in the original container, protect from moisture and heat.

Esomeprazole can affect the pharmacokinetics of several medicines; interactions are categorized by clinical significance.

Major Interactions (Avoid)

• Clopidogrel: reduced antiplatelet effect may increase cardiovascular risk.
• Atazanavir (and other protease inhibitors): decreased absorption leading to loss of antiviral efficacy.
• HIV protease inhibitors (e.g., ritonavir): impaired drug levels and possible treatment failure.

Moderate Interactions (Monitor Closely)

• Digoxin: increased serum concentrations may require dose adjustment.
• Warfarin: enhanced anticoagulant effect may raise bleeding risk.
• Methotrexate: reduced clearance can increase toxicity, especially at high doses.